A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Recent work has conclusively shown that partial moles can transform into choriocarcinoma and placental-site trophoblastic tumor, therefore all patients with partial moles and complete moles ...

Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon ...

Scientists have found a way to combat a rare, aggressive form of cancer affecting pregnant women and to better ensure the drug used for the disease reaches tumor cells without damaging healthy tissue.

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...

Or, it could indicate: A twins or multiples pregnancy A molar pregnancy Down syndrome Choriocarcinoma (a rare type of cancer that happens in the uterus early in pregnancy, as the placenta develops ...

Gestational trophoblastic disease (GTD) arises from faulty placental cells and comprises several rare conditions including molar pregnancies and choriocarcinoma. Molar pregnancies can initially be ...

Findings of the study into choriocarcinoma ... It can also happen following a molar pregnancy (no embryo forms, and the placental tissue grows abnormally) and even after a full-term pregnancy.